Contact this trialFirst, we need to learn more about you.
Small Molecule Kinase Inhibitor
Savolitinib + Osimertinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Orange City, Florida
This trial will compare the effects of two cancer treatments in people with EGFR-mutated NSCLC that has progressed despite treatment with osimertinib.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.